Linda M. Henricks
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 16
- Pancreatic and Hepatic Oncology Research 8
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 3
- Neutropenia and Cancer Infections 2
- Pharmacology top 2%
-
- Biochemical and Molecular Research 8
-
- Medical Imaging Techniques and Applications 1
-
- Neuroendocrine Tumor Research Advances 1
- Co-authors
- Jan H.M. SchellensJesse J. SwenJos H. BeijnenAnnemieke CatsUrsula AmstutzKelly E. CaudleTeri E. KleinHoward L. McLeod
- Cited by
- OncologyPharmacologyCancer Research
- Journals
- Nature Cell Biology (1 paper)British Journal of Cancer (1 paper)Annals of Oncology (2 papers)
- Partner nations
- NetherlandsSwitzerlandUnited States
In The Last Decade
Linda M. Henricks
20 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 785
- Pharmacology 195
- Cancer Research 112
- Molecular Biology 461
- Pathology and Forensic Medicine 103
Countries citing papers authored by Linda M. Henricks
This map shows the geographic impact of Linda M. Henricks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda M. Henricks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda M. Henricks more than expected).
Fields of papers citing papers by Linda M. Henricks
This network shows the impact of papers produced by Linda M. Henricks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda M. Henricks. The network helps show where Linda M. Henricks may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Linda M. Henricks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 9 | |
| 3 | 2022 | 0 | |
| 4 | 2020 | 47 | |
| 5 | 2018 | 16 | |
| 6 | 2018 | 27 | |
| 7 | 2018 | 11 | |
| 8 | 2018 | 39 | |
| 9 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Updatebreakdown → | 2017 | 406 |
| 10 | 2017 | 60 | |
| 11 | 2017 | 81 | |
| 12 | 2017 | 14 | |
| 13 | 2017 | 23 | |
| 14 | 2016 | 18 | |
| 15 | 2016 | 40 | |
| 16 | 2016 | 29 | |
| 17 | 2015 | 97 | |
| 18 | 2015 | 52 | |
| 19 | 2015 | 73 | |
| 20 | 2015 | 73 |
About Linda M. Henricks
Linda M. Henricks is a scholar working on Oncology, Geriatrics and Gerontology and Biochemistry, having authored 22 papers that have together received 1.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (16 papers), Biochemical and Molecular Research (8 papers), Pancreatic and Hepatic Oncology Research (8 papers), Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (3 papers), Neutropenia and Cancer Infections (2 papers), Medical Imaging Techniques and Applications (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Oncology (785 citations), Pharmacology (195 citations) and Cancer Research (112 citations). Linda M. Henricks has collaborated with scholars based in Netherlands, Switzerland and United States. Frequent co-authors include Jan H.M. Schellens, Jesse J. Swen, Jos H. Beijnen, Annemieke Cats, Ursula Amstutz, Kelly E. Caudle, Teri E. Klein, Howard L. McLeod, Henk‐Jan Guchelaar and Robert B. Diasio. Their work appears in journals such as Nature Cell Biology, British Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.